Schering-Plough Products Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per recall — FDA D-139-2013
Failed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the degradation product testing detected during stability monitoring.